Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII) -- Ignore unavailable to you. Want to Upgrade?

To: BRAVEHEART who wrote (697)	11/5/1999 10:22:00 AM
From: BRAVEHEART	Read Replies (2) \| Respond to of 1494

Anyone planning on attending the annual shareholders meeting on Nov 11, 1999? The letter to the shareholders essentially highlights a series of events one can expect to start to unfold between now and late spring. Any positive development from here on out should signal significant added market interest in NTII and translate into increased shareholder value. It should be another interesting year folks. The Quintiles run diabetic neuropathic pain trial is the key piece to the puzzle. The results are expected by late Dec. Positive results and we are on our way... BEST WISHES Jeffrey